The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.

Eli Lilly LLY reported 54% revenue growth in the third quarter as its diabetes and obesity drug tirzepatide ...

GLP-1 drugs, synthetic versions of a natural hormone, are revolutionizing weight loss and type 2 diabetes treatment. By ...

Certain medications, such as blood thinners, may interact with omega-3 supplements. Learn more about omega-3 interactions here.

Eli Lilly remains a top GARP opportunity, with Q3 results reinforcing its robust business growth and dominance in incretin ...

Earlier this year, Meghan revealed that she’d used Mounjaro — among other “lifestyle changes” — to “help” her after her second pregnancy.

In April, the “All About That Bass” singer admitted to using Mounjaro in order “to be the healthiest, strongest version” of ...

Related: 26 Pairs Of Celebrities Who Look Sooo Much Alike, It’s A Little Uncanny This came shortly after Amy detailed her ...

TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition ...

The comedian, 44, took to Instagram to share some sizzling new snaps on Thursday, after shedding pounds with the help of ...

Major stock indexes declined Thursday as investors digested several big tech earnings reports and awaited more after the ...